Literature DB >> 22288967

A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country.

Seema Kashyap1, Sumita Sethi, Rachna Meel, Neelam Pushker, Seema Sen, Mandeep Singh Bajaj, Mahesh Chandra, Supriyo Ghose.   

Abstract

CONTEXT: In eyes enucleated for retinoblastoma, presence of histopathologic high-risk factors is associated with a higher risk of local recurrence and systemic metastasis.
OBJECTIVE: To evaluate histopathologic features in children with retinoblastoma in our population and establish relationship between age, tumor differentiation, and high-risk features.
DESIGN: Retrospective histopathologic analysis of 609 consecutively enucleated eyes for advanced intraocular retinoblastoma during a 10-year period. A nonparametric test was used to establish relationship between age, differentiation, and high-risk features.
RESULTS: Poorly differentiated retinoblastoma presented in 80.3% and well-differentiated in 19.7% of eyes. Well-differentiated tumors presented earlier (median 1.2 years) than poorly differentiated tumors (median 2.5 years) (P < .001). One hundred fourteen eyes (18.7%) had 1 and 138 (22.7%) had at least 2 high-risk histopathologic factors. Invasion of anterior chamber was found in 10.0%, iris in 10.7%, ciliary body in 6.7%, sclera in 13.7%, massive choroid in 24.6%, postlaminar optic nerve in 16.1%, resected margin of the optic nerve in 7.4%, and extrascleral tissue in 4.1% of eyes. Extensive necrosis was seen in 31.0% of eyes. Poorly differentiated tumors were significantly associated with presence of more than 1 high-risk histopathologic feature (P < .001) and extensive necrosis (P < .001).
CONCLUSION: Poorly differentiated tumors present at a later age and are associated with presence of multiple high-risk factors and extensive necrosis. In our population, high-risk histopathologic factors are present in a significant number of eyes. Because we have included only primarily enucleated eyes, this could truly represent the distribution of high-risk histopathologic factors in children with retinoblastoma.

Entities:  

Mesh:

Year:  2012        PMID: 22288967     DOI: 10.5858/arpa.2010-0759-OA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  10 in total

1.  Extraocular retinoblastoma in Indian children: clinical, imaging and histopathological features.

Authors:  Sumita Sethi; Neelam Pushker; Seema Kashyap; Sanjay Sharma; Mridula Mehta; Sameer Bakhshi; Saurbhi Khurana; Supriyo Ghose
Journal:  Int J Ophthalmol       Date:  2013-08-18       Impact factor: 1.779

2.  Evaluation of high-risk features of primary enucleation of patients with retinoblastoma in a tertiary center of a developing country in the era of intra-arterial chemotherapy.

Authors:  Funda Dikkaya; Ahmet Murat Sarıcı; Firuze Erbek; Tiraje Celkan; Mehmet Serhat Mangan; Övgü Aydın; Cuyan Demirkesen; Halit Pazarlı
Journal:  Int Ophthalmol       Date:  2017-01-05       Impact factor: 2.031

3.  Correlation between clinical presentations, radiological findings and high risk histopathological features of primary enucleated eyes with advanced retinoblastoma at Queen Sirikit National Institute of Child Health: 5 years result.

Authors:  Supawan Surukrattanaskul; Bungornrat Keyurapan; Nutsuchar Wangtiraumnuay
Journal:  PLoS One       Date:  2022-07-20       Impact factor: 3.752

4.  High-Risk Histopathologic Features of Retinoblastoma Treated at a Tertiary Hospital in West Java, Indonesia.

Authors:  Nur Melani Sari; Regina Hadiputri; Maya Sari Kuntorini; Hasrayati Agustina; Friska Mardianty
Journal:  Ocul Oncol Pathol       Date:  2021-07-20

5.  Survival outcomes of unilateral retinoblastoma based on pathological risk stratification-experience at a tertiary care centre in Pakistan.

Authors:  Najma Shaheen; Naila Inayat; Sehar Bashir; Umer Nisar Sheikh; Muhammad Abu Bakar; Palwasha Rehman
Journal:  Ecancermedicalscience       Date:  2022-03-01

6.  Clinicopathological Findings of Retinoblastoma: A 10-Year Experience from a Tertiary Hospital in Kampala, Uganda.

Authors:  James Joseph Yahaya; Belson Rugwizangoga; Alex Mremi; Asafu Munema
Journal:  J Ophthalmol       Date:  2019-06-16       Impact factor: 1.909

7.  High risk histopathological factors in retinoblastoma in upfront enucleated eyes: An experience from a tertiary care centre of Pakistan.

Authors:  Nausheen Yaqoob; Salima Mansoor; Kanwal Aftab; Bushra Kaleem; Ahmer Hamid; Saba Jamal
Journal:  Pak J Med Sci       Date:  2022-01       Impact factor: 1.088

8.  p16(INK4a) expression in retinoblastoma: a marker of differentiation grade.

Authors:  Yue Liu; Xiufeng Zhong; Shangtao Wan; Wenxin Zhang; Jianxian Lin; Ping Zhang; Yongping Li
Journal:  Diagn Pathol       Date:  2014-12-11       Impact factor: 2.644

9.  Retinoblastoma in Mongolia: Clinical characteristics and survival from 1987 to 2014.

Authors:  Tsengelmaa Chuluunbat; Baasankhuu Jamiyanjav; Baylag Munkhuu; Uranchimeg Bazarsad; Altankhuu Molom; Ling-Yuh Kao; Wei-Chi Wu
Journal:  Taiwan J Ophthalmol       Date:  2016-05-20

10.  UHRF1 downmodulation enhances antitumor effects of histone deacetylase inhibitors in retinoblastoma by augmenting oxidative stress-mediated apoptosis.

Authors:  Jong Kyong Kim; Guangyan Kan; Yu Mao; Zhixuan Wu; Xionghong Tan; Heng He; Chunsik Lee
Journal:  Mol Oncol       Date:  2019-12-13       Impact factor: 6.603

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.